GO Main Menu Go Main Contents Go Bottom Menu

CelltrionHealthcare

gnb show

MENU

Gnb close

RegkironaTM

  • RegkironaTM image
    • Product Name : RegkironaTM
    • INN : Regdanvimab
    • Indications : COVID-19
    • Protein Type : Monoclonal antibody (mAb)
    • Mechanism of Action : It binds to the receptor binding domain (RBD) of the spike(s) protein of SARS-CoV-2 consequently blocking cellular entry and SARS-CoV-2 infection.
    • Drug Approval Status : Korea, Europe, Indonesia*, Brazil*, Peru*, Australia* *Emergency Use of Authorization(EUA) or Conditional Marketing Authorization(CMA)

    This product description is for medical and educational purposes only.
    They are not intended to promote PR or sales campaigns.
    For more details, please consult a doctor or a medical specialist. This site is intended for all over the world.